The Lining That Ages: What One Layer of Cells Says About Your Arteries (And What Polyphenol Trials Found)

Chapter 1

The Accident in Furchgott’s Lab

In the late 1970s, a pharmacologist in Brooklyn had a problem he could not explain. Robert Furchgott had spent years studying how arteries respond to chemical signals. One of those signals, acetylcholine, was known to widen blood vessels in living animals. Yet whenever Furchgott hung a strip of artery in his laboratory bath and added acetylcholine, the strip did the opposite. It tightened.

For a careful scientist, a result like that is maddening. The chemical was the same. The artery was the same. Only the setting had changed, and somewhere in that change the instruction "relax" was being lost.

The answer arrived by accident. A preparation that had been handled differently from usual, without the routine rubbing of its inner surface, behaved like a living vessel: add acetylcholine, and it relaxed. Furchgott and his colleague John Zawadzki followed the clue with deliberate experiments. When the thin inner surface of the artery was left intact, acetylcholine relaxed the vessel. When that surface was gently rubbed away, the relaxation disappeared.

This article is about that layer. We will look at what it does, how scientists measure it in a living person in a few minutes, how it changes with age, and what trials of regular movement, resveratrol and quercetin have actually found. The goal is simple: by the end you should understand how your arteries age from the inside, and which levers have evidence behind them.

Section 1

Rubbed Away and Restored

Furchgott and Zawadzki published their findings in Nature in 1980. The paper’s title said it plainly: endothelial cells play an obligatory role in the relaxation of arterial smooth muscle by acetylcholine.

The word that mattered was obligatory. The smooth muscle that makes up most of an artery’s wall can tighten or loosen, but for this signal it could not respond on its own. It needed a message from the cells lining the inside of the vessel. Remove them, and the message never arrived.

The rubbing that had spoiled the earlier experiments was not a mistake anyone had noticed, because nobody had thought the lining mattered. It had been treated as wallpaper: a passive surface that blood flowed past. Furchgott’s result turned the wallpaper into the control room.

The organ bath: a ring of artery hangs in warm, oxygenated liquid so researchers can watch it tighten or relax.

Section 2

One Cell Thick, Everywhere

That lining is called the endothelium. It is a single layer of flattened cells that covers the inner surface of every blood vessel in your body, from the aorta to the smallest capillary.

Because it sits between the blood and the vessel wall, the endothelium is in constant contact with everything that travels in your circulation: the pressure of each heartbeat, the drag of flowing blood, and whatever is dissolved in it. It responds to all of this. It helps decide how wide a vessel should be, how easily white blood cells can stick to the wall, and how readily blood clots.

One way to picture it is as the skin on the inside of your arteries. Like the skin on the outside of your body, it is thin, it is everywhere, and it is busy. Unlike your outer skin, you cannot see it age.

Section 3

The Messenger Was a Gas

Furchgott called the unknown signal endothelium-derived relaxing factor. For several years nobody knew what it was. When the chemistry was finally worked out, the answer surprised almost everyone: the messenger was nitric oxide, a small, short-lived gas.

The endothelium makes nitric oxide on demand. It drifts a fraction of a millimetre into the muscle layer next door, tells the muscle to relax, and is gone within seconds. The artery widens, blood flows more freely, and the signal fades until it is needed again.

The discovery was important enough that Furchgott shared the 1998 Nobel Prize in Physiology or Medicine with Louis Ignarro and Ferid Murad for work on nitric oxide as a signalling molecule in the cardiovascular system.

Section 4

More Than a Relaxing Signal

Widening the vessel is the job nitric oxide is best known for, but it is not the only one. The same molecule helps keep the inner surface of the artery calm and non-sticky.

A healthy, nitric-oxide-rich lining makes it harder for platelets to clump on the vessel wall and harder for white blood cells to latch on and burrow in. In other words, the endothelium is not only a dimmer switch for blood flow. It is also part of the reason blood keeps gliding smoothly past the wall instead of snagging on it.

This is why researchers describe a well-functioning lining with words like quiescent or protective, and a struggling one as activated. When nitric oxide runs low, the balance tips: vessels relax less readily, and the surface becomes a little more inviting to cells that should flow past. None of this is visible from the outside, and none of it is felt. That is exactly what makes a way of measuring it so valuable.

Chapter 2

How the Lining Ages

For decades after Furchgott’s discovery, studying the endothelium in people meant invasive tests: catheters threaded into arteries and drugs infused directly into the bloodstream. By the 1990s, researchers had found a way to ask the same question with nothing more than a blood-pressure cuff and an ultrasound probe.

The question was the one Furchgott had asked of his artery rings. When the lining receives a signal to relax the vessel, how well does it respond?

Section 1

A Cuff, a Probe and Five Minutes

The test is called flow-mediated dilation, usually shortened to FMD. It goes like this.

You lie quietly while an ultrasound probe measures the width of the main artery in your upper arm. A cuff on the forearm is then inflated for about five minutes, briefly stopping the flow of blood to the hand. When the cuff is released, blood rushes back through the artery.

That surge drags along the endothelium. A healthy lining senses the drag and releases nitric oxide, and over the next minute or so the artery widens by a few percent. The ultrasound records how much.

Because the response depends largely on nitric oxide from the endothelium, FMD has become one of the most widely used ways to study endothelial function in humans. It is sensitive to everyday factors such as a recent meal, caffeine, exercise, time of day and smoking, which is why careful studies control them closely.

Flow-mediated dilation: a forearm cuff is released and an ultrasound probe on the upper arm measures how much the artery widens.

Section 2

Decades Earlier Than You Might Think

In 1994, David Celermajer and colleagues used this method in 238 healthy adults across a wide age range. The pattern was striking.

In men, flow-mediated dilation began to decline from around the early forties. In women, it held up longer and then fell more steeply from around the time of menopause. In both, the lining’s response was weaker in later life than in early adulthood, even in people with no diagnosed heart condition.

Later work, summarised by Douglas Seals and colleagues in 2011, helps explain why. With age, the endothelium tends to produce less usable nitric oxide. Part of the reason is oxidative stress: reactive molecules that react with nitric oxide and neutralise it before it can reach the muscle. Part is a low-grade inflammatory state in the vessel wall. The lining is still there. Its messages simply arrive weaker.

This is the quiet part of vascular ageing. Long before anyone notices anything, the inside of the artery is gradually losing some of its ability to tell the vessel to relax.

Section 3

Why Researchers Pay Attention

If FMD were only a laboratory curiosity, it would not matter much to you. The reason researchers care is what it is associated with.

Several observational meta-analyses, which pool long-term studies of thousands of people, have found that people with lower flow-mediated dilation tend to have more cardiovascular events over the following years than people with higher values.

It is important to read that carefully. These are associations, not proof that improving FMD by itself changes those outcomes. A weaker lining may be a marker of many other things going on. But it explains why the endothelium has become a target for research: it is measurable, it changes with age, and it may be an early window into how the circulation is ageing.

A useful comparison is a car’s dashboard. A warning light that comes on more often in cars that later break down is worth paying attention to, even though covering the light with tape would fix nothing. FMD works in a similar way. What researchers want to know is whether the things that improve the reading, such as exercise, also improve the engine underneath. For movement, the wider evidence on heart health is reassuring. For supplements, the long-term question is still open, and we will be careful about that in the next two chapters.

🔒 LOCKED: EXCLUSIVE READER REWARD

There is a private, unadvertised reader reward waiting at the end of this article.

Read the next two chapters closely. Score at least 4 out of 5 on the Final Master Quiz at the bottom of the page and we will unlock a reward chosen for exactly the reader who has just understood this science, together with a private code that never appears on our public pages. Valid for 14 days, until 29 October 2026.

The answers are all in the chapters ahead…

Chapter 3

What Moves the Lining

If the endothelium only ever declined, this would be a short and gloomy chapter. The more interesting finding is that, in people, the lining’s response can change within weeks. Some things make it worse for a few hours, such as a cigarette or a very fatty meal. Others appear to make it better. The strongest evidence starts with your legs.

Section 1

Movement Comes First

In 2000, Christopher DeSouza and colleagues at the University of Colorado compared healthy men of different ages. Sedentary older men had weaker endothelium-dependent dilation than young men, while older men who had been endurance-trained for years looked much more like the young.

The key part came next. A group of previously sedentary middle-aged and older men started a programme of regular brisk walking. After about three months, their endothelium-dependent dilation had improved to levels similar to those of the long-term exercisers.

The mechanism makes sense once you know about FMD. Every time you walk briskly, blood flow through your arteries increases and the drag on the endothelium rises. That repeated shear stress is exactly the signal that prompts the lining to make nitric oxide. Exercise is, in effect, a daily flow-mediated dilation test that the body adapts to.

If you read our article on walking speed as the sixth vital sign, or this week’s piece on the memory that fades first, you will notice a theme. The same habit keeps appearing at the top of the evidence.

Section 2

Resveratrol and the Cuff Test

Resveratrol is a polyphenol found in small amounts in grape skins, red wine and peanuts, and in much larger amounts in the roots of Japanese knotweed, which is where most supplemental resveratrol comes from. It has been studied for many reasons. For the endothelium, the most relevant human evidence comes from a series of trials led by Rachel Wong in Adelaide.

In 2011, Wong’s group gave 19 adults who were overweight or obese and had high-normal blood pressure or mildly raised blood pressure single doses of 30 mg, 90 mg and 270 mg of resveratrol, or a placebo, on separate days. One hour later, flow-mediated dilation was higher after resveratrol than after placebo, and the response rose with the dose.

The design is worth a moment, because it makes the result easier to trust. Each participant tried every dose and the placebo, in a random order, without knowing which they had taken. That way each person acted as their own comparison, which helps when the group is small. A response that climbs with the dose is also the kind of pattern researchers look for when deciding whether an effect is likely to be real rather than chance.

In 2013, the same team tested daily use. Twenty-eight obese but otherwise healthy adults took 75 mg of resveratrol a day for six weeks, or a placebo. FMD improved with resveratrol compared with placebo.

Meta-analyses that pool these and similar trials, mostly in people with metabolic risk factors, have found a modest improvement in FMD with resveratrol. Pooled analyses of blood pressure, by contrast, have not found a clear overall effect. That distinction matters: resveratrol appears to influence how the lining responds more consistently than it changes the numbers on a blood-pressure monitor.

One more honest point. When you swallow resveratrol, your body absorbs much of it but quickly converts it into other forms. A 2004 study by Thomas Walle found that only a very small fraction circulates as unchanged resveratrol. Researchers are still working out how much of the effect comes from resveratrol itself and how much from these related compounds.

Grapes, Japanese knotweed and dark berries: natural sources of resveratrol and related polyphenols.

Section 3

Quercetin: An Acute Signal, a Mixed Picture

Quercetin is one of the most common flavonoids in the diet, found in onions, apples, capers, tea and the flower buds of the Japanese pagoda tree (Sophora japonica), a common source for supplements.

In a 2008 study, Wai Mun Loke and colleagues gave 12 healthy men a single 200 mg dose of pure quercetin. Over the next few hours, blood markers of nitric oxide went up and levels of endothelin-1, a signal that narrows blood vessels, went down. It was a small, short study, but it showed quercetin acting on the same balance of signals the endothelium controls.

Longer trials are more mixed. In 2007, Randi Edwards and colleagues gave 730 mg of quercetin a day for four weeks. Blood pressure fell in participants with stage 1 hypertension, but not in those with prehypertension. Trials using lower doses have produced mixed results on vascular measures.

Put simply, quercetin has a plausible effect on the nitric-oxide balance in the short term, with a less consistent picture over weeks. That is worth knowing before you form expectations.

Section 4

Reading These Trials Fairly

Before moving on, it helps to be clear about what these studies can and cannot tell you.

Chapter 4

Putting It Together

You now know more about the inside of your arteries than most people ever learn. The lining that Furchgott nearly rubbed away is a living control system. It weakens gradually with age, it can be measured in five minutes, and it responds to what you do. The question is what to do with that knowledge.

Section 1

The Doses, Stated Plainly

If you decide to add polyphenols to your routine, it is worth knowing exactly how the amounts compare with the research.

The resveratrol FMD trials used 30 to 270 mg as single doses and 75 mg a day over six weeks. The acute quercetin study used 200 mg; the four-week blood-pressure trial used 730 mg a day.

One capsule of Nutriop Resveratrol + Quercetin provides 500 mg of trans-resveratrol (from Japanese knotweed) and 200 mg of quercetin (from Sophora japonica). So the quercetin matches the amount in the acute nitric-oxide study, and the resveratrol is higher than the amounts used in the FMD trials. More is not automatically better, and nobody has run an FMD trial on this exact combination. We would rather you know that than assume it.

We chose this pairing because the two compounds are among the most studied dietary polyphenols, and because they act on the same nitric-oxide balance described in this article. In our article on senescent cells we looked at the same two molecules for a different reason. Here the focus is the lining.

Resveratrol + Quercetin, shown with Japanese knotweed and Sophora japonica, the plant sources of its two ingredients.

Section 2

Who It Suits, and Who Should Ask First

It may suit you if you are in midlife or beyond, already move regularly or are starting to, and want to add the two polyphenols with the most human vascular research behind them to your daily routine.

Talk to your doctor or pharmacist first if you take blood thinners or antiplatelet medicines, take blood-pressure medication, take several prescription medicines, are pregnant or breastfeeding, or have a scheduled operation.

The reason is practical. In a 2010 study by Chow and colleagues, healthy volunteers who took 1 g of resveratrol a day for four weeks showed changes in the activity of several liver enzymes (CYP enzymes) that process many common medicines. That does not make resveratrol unsafe, but it means interactions are possible. For quercetin, a 2018 safety review by Andres and colleagues found that intakes up to about 1 g a day for up to 12 weeks were generally well tolerated in human studies.

Section 3

The Order of Operations

If you remember one thing from this article, make it the order.

This is also how to judge any product, including ours. A capsule that is presented as a substitute for movement deserves suspicion. A capsule that is positioned as something you add once the foundations are in place is making an honest claim.

Section 4

What to Expect, Honestly

You cannot feel your endothelium, and there is no home test for flow-mediated dilation. So it helps to set expectations that match the evidence.

What the trials measured was a change in how the upper-arm artery responds to a cuff, in a laboratory, under controlled conditions. What they did not measure was how anyone felt, or what happens over years. A polyphenol supplement is therefore not something to judge by a sensation in the first week.

What you can track is the part with the strongest evidence. Count your brisk walking minutes each week and aim to make them a habit. Ask your doctor to check your blood pressure at your regular appointments. If you decide to add resveratrol and quercetin, take them consistently as directed on the label, and treat them as one part of a routine whose foundations you can see and measure.

If you have a question about your own heart or circulation, or you notice symptoms such as chest discomfort, unusual breathlessness or leg pain when walking, speak to your doctor. Nothing in this article replaces that conversation.

🎁 ONE STEP LEFT: YOUR READER REWARD

You have read all four chapters. Five questions now stand between you and your reward.

Score at least 4 out of 5 on the Final Master Quiz below and your private reader code unlocks instantly. Valid until 29 October 2026.

Everything you need is in the chapters you have just read.

Complete Reference List

The discovery of the endothelium’s role

How the lining ages, and why it matters

Exercise

Resveratrol

Quercetin

Safety